How do the results from oral Wegovy and injections compare?
Wegovy pills and injection are weight loss treatments that produce similar results in adults with obesity. In the OASIS 4 clinical trial, adults taking the 25mg Wegovy pill once daily lost around 13.6% of their body weight over 64 weeks. In the STEP 1 trial of the 2.4mg weekly injection, the average weight loss was 14.9% over 68 weeks. All participants also followed a reduced-calorie diet and increased physical activity.
Is the Wegovy pill as effective as Wegovy injections? For most patients, yes. The 1.3% gap between pill and injection is likely too small to matter in practice. Wegovy pill results varied widely in the trial.
Some people lost more than 15% of their body weight. Others plateaued earlier. In practice, individual results vary more widely than the average gap between pill and injection.
The pill and injection put about the same amount of the drug into the bloodstream once you reach the highest dose. When STEP 1 participants stopped taking the Wegovy injection, most put the weight back on. The same pattern likely applies to the pill over the long term, though data on regain rates has not yet been published.
| Outcome | Wegovy pill (OASIS 4) | Wegovy injection (STEP 1) | Wegovy higher dose injection (STEP UP) |
| Maintenance dose | 25mg daily | 2.4mg weekly | 7.2mg weekly |
| Trial length | 64 weeks | 68 weeks | 72 weeks |
| Average weight loss | ~13.6% | ~14.9% | ~18.7% |
A higher injection dose is also available. In the STEP UP trial, the 7.2mg weekly injection produced an average weight loss of 18.7% over 72 weeks. This dose is an option for people who do not reach their weight goals on 2.4mg.
How do the side effects compare?
Wegovy pill vs injection side effects largely overlap because both formulations deliver the same drug. The main side effects of the Wegovy pill differ from the injection in two main ways. Injection-site reactions only happen with the pen, and vomiting is slightly more common with the pill at the full dose.
Roughly half of adults on the daily pill experienced nausea at some point in the trial. The rate on the weekly injection was around the same. Almost a third of people on the pill experienced vomiting. On the injection, it was closer to a quarter.
Diarrhoea was more common on the injection (around a third) than the pill (around a fifth). Dyspepsia, which feels like heartburn or indigestion, went the other way: roughly 18% on the pill and 10% on the injection.
Skin sensitivities, or dysaesthesia, were slightly more common on the tablet. Symptoms include tingling, burning, or unusual pain on touch. Both OASIS 4 and the earlier OASIS 1 trial of oral semaglutide reported dysaesthesia. Dysaesthesia rates were notably higher with Wegovy 7.2mg injections. In the STEP UP trial, around 1 in 5 people on the higher dose reported skin sensitivity symptoms, compared with about 1 in 20 on the 2.4mg dose.
Most side effects hit during the early weeks of dose escalation. This is the hardest part of the routine and the most common reason for stopping treatment. Symptoms usually settle once you have spent a few weeks on the same dose, or once you reach the maintenance dose, which is why the schedule steps up gradually.
Around 1 in 20 people on the injection get mild redness or itching at the injection site. The pill does not cause this. Serious side effects were uncommon across trials for both formats.
| Side effect | Wegovy pill | Wegovy injection |
| Nausea | ~47% | ~44% |
| Vomiting | ~31% | ~25% |
| Diarrhoea | ~18% | ~32% |
| Dyspepsia (indigestion and heartburn) | ~18% | ~10% |
| Dysesthesia (altered skin sensation) | ~5% | ~12% |
| Injection-site reactions | None | ~5% |
What is the difference in how you take them?
The biggest difference between the Wegovy pill and injection is the daily dosing and fasting requirement. You should swallow one tablet whole with up to 120ml of plain water, on an empty stomach, first thing in the morning. Do not crush, split, or chew it.
Wait at least 30 minutes before you eat, drink, or take other tablets. Getting this right matters. Each time you break the 30-minute fasting window, less of the drug is absorbed. This is where most routines start to slip.
The Wegovy injection works on a weekly dosing schedule instead. You inject once a week into the stomach, thigh, or upper arm using a pre-filled pen.
The injection has no fasting rules and can be used at any time of day. Rotate the injection site each week to reduce the risk of skin irritation. Pick a day that works for you and stick to it.
For anyone weighing up Wegovy pen vs pill, the real question is which routine you can keep up with this weight loss medication. If you are considering switching from Wegovy injection to the pill, we can guide you through the process.
How does the cost compare between Wegovy tablets and injections?
UK pricing for the Wegovy pill has not been set yet. A direct Wegovy pill vs injection cost comparison is not possible. The Wegovy pill vs injection cost gap will depend on UK launch pricing.
NovoCare Pharmacy is Novo Nordisk’s US direct-to-patient programme. The Wegovy pill is listed there at between $149 and $299 a month, depending on strength. Injectable Wegovy costs between $199 and $399 a month on the same programme. The full Wegovy list price in the US is around $1,349 a month, but most people pay less through insurance or savings programmes.
The pill does not need cold storage or costly pen devices, which should make it cheaper to produce. In the UK, whether the Wegovy pill is cheaper than the injection will depend on how Novo Nordisk prices the two formulations at launch.
Is Wegovy pills or injections better for weight loss?
Which is better, the Wegovy pill or injection? Neither format is objectively better for weight management. The Wegovy pill vs Wegovy injection choice is about routine, not effectiveness.
Both are GLP-1 medications that deliver semaglutide at similar levels in the body. The difference is where each routine becomes harder to maintain.
With the pill, the routine can slip before you notice. Cut the fasting window short, and less of the drug gets through. If your mornings vary, you rely on an early coffee, or you work unpredictable shifts, the pill might underdeliver. But for some people, avoiding needles makes the trade-off worth it.
With a weekly injection, it can be easier to put off. A daily pill builds consistency simply because you take it every morning.
What about the dose difference?
The Wegovy pill dose is much higher than the injection dose, but it is not stronger. The maintenance dose is 25mg for the daily pill, and 2.4mg for the weekly injection. Why the Wegovy pill dose is higher than the injection comes down to absorption. Less than 1% of the swallowed dose reaches the bloodstream, compared with roughly 89% from the injection.
The gut breaks down most of the tablet before it can be absorbed. This means a much higher dose is needed to deliver the same amount of drug as the injection. Once absorbed, the amount of drug in the bloodstream matches what the weekly injection provides. Similar blood levels explain the similar weight loss.
Join now
When should I see a doctor?
Complete our online consultation before you start either formulation. Make sure to mention any medical conditions you have or medication you take. Your prescriber will need to review any history of pancreatitis or gallbladder disease before starting either format. The same applies to anyone with a personal or family history of medullary thyroid cancer (MTC) or multiple endocrine neoplasia type 2 (MEN 2).
Contact our clinical team if side effects do not settle within a few weeks or feel unmanageable. Severe or persistent nausea or repeated vomiting needs a prompt review. Severe stomach pain that will not go away can be a sign of pancreatitis and needs urgent attention. Dial 999 for any sudden trouble breathing or swelling of the face or throat.
If you notice sudden vision changes, especially loss of vision in one eye, seek urgent care. Speak to your doctor or visit A&E.
This can be a sign of NAION (non-arteritic anterior ischaemic optic neuropathy), a rare but serious eye condition. Speak to your doctor if you notice new or worsening changes in mood, including thoughts of self-harm or suicide. For any urgent concern, go to A&E.
If you are already on Wegovy and thinking about switching formats, complete a new online consultation first. We can provide the correct strength to move to to prevent side effects.
Key takeaways
- The numbers: approximately 13.6% average weight loss with the Wegovy pill and 14.9% with the 2.4mg injection. The gap is too small to matter clinically.
- Wegovy pill vs jab: same drug, different routines, similar results. The pill is taken daily on an empty stomach. The injection is weekly with no fasting rules.
- Side effect profiles look similar across Wegovy tablets and injections. Injection-site reactions only happen with the pen.
- UK pricing for oral Wegovy is not yet confirmed.
- Pill vs injection Wegovy: results depend on consistency of use and adherence to dosing instructions.
References
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity (OASIS 4), New England Journal of Medicine, 2025 [Accessed 20 April 2026]
Oral Semaglutide 50 mg Taken Once Per Day in Adults with Overweight or Obesity (OASIS 1), The Lancet, 2023 [Accessed 20 April 2026]
Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1), New England Journal of Medicine, 2021 [Accessed 20 April 2026]
Once-Weekly Semaglutide 7.2 mg in Adults with Obesity (STEP UP), The Lancet Diabetes & Endocrinology, 2025 [Accessed 24 April 2026]
Weight Regain and Cardiometabolic Effects After Withdrawal of Semaglutide: The STEP 1 Trial Extension, Diabetes, Obesity and Metabolism, 2022 [Accessed 20 April 2026]
Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials, Clinical Pharmacokinetics, 2021 [Accessed 20 April 2026]
Wegovy 2.4 mg, FlexTouch Solution for Injection in Pre-filled Pen – Summary of Product Characteristics, Electronic Medicines Compendium, 2025 [Accessed 20 April 2026]
Wegovy (Oral Semaglutide Tablets) Prescribing Information, NDA 218316, US Food and Drug Administration, 2025 [Accessed 20 April 2026]
Wegovy (Semaglutide Injection) Prescribing Information, NDA 215256, US Food and Drug Administration, 2025 [Accessed 20 April 2026]
NovoCare Pharmacy Wegovy Price Guide, Novo Nordisk, 2026 [Accessed 20 April 2026]
Wegovy Wholesale Acquisition Cost (List Price), Novo Nordisk, 2026 [Accessed 20 April 2026]
Authorship
Authored by Shereen Amin
Pharmacist Independent Prescriber & Medical Writer
GPhC: 2073003
Shereen is a Pharmacist Independent Prescriber and medical writer with over ten years' experience across NHS primary care, digital health and specialist services. She writes evidence-based health content for Simple Online Pharmacy, turning complex clinical information into guidance patients can actually use.
Medically Reviewed by Zahra Qureshi
Senior Pharmacist
GPhC: 2216331
Zahra began her pharmacy career in community pharmacy, building a strong foundation in patient care and medication safety. She joined Simple Online Pharmacy as a locum pharmacist and quickly progressed to a senior role, supporting the pharmacy and operations teams. Zahra is passionate about ensuring patient guidance is safe, clinically sound, and easy to understand, making a positive difference to patients’ lives.
